Article info

Download PDFPDF
Nuclear-specific accumulation of telomerase reverse transcriptase (TERT) mRNA in TERT promoter mutated follicular thyroid tumours visualised by in situ hybridisation: a possible clinical screening tool?

Authors

  1. Correspondence to Dr C Christofer Juhlin, Department of Pathology and Cytology, Radiumhemmet, P1:02, Karolinska University Hospital Solna, 17176, Stockholm, Sweden; christofer.juhlin{at}ki.se
View Full Text

Citation

Hellgren LS, Olsson A, Kaufeldt A, et al
Nuclear-specific accumulation of telomerase reverse transcriptase (TERT) mRNA in TERT promoter mutated follicular thyroid tumours visualised by in situ hybridisation: a possible clinical screening tool?

Publication history

  • Received April 18, 2021
  • Revised April 26, 2021
  • Accepted April 28, 2021
  • First published May 19, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.